SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-059519
Filing Date
2024-05-14
Accepted
2024-05-14 16:05:47
Documents
54
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q pepg-20240331.htm   iXBRL 10-Q 1759990
2 EX-31.1 pepg-ex31_1.htm EX-31.1 18236
3 EX-31.2 pepg-ex31_2.htm EX-31.2 17226
4 EX-32.1 pepg-ex32_1.htm EX-32.1 7648
5 EX-32.2 pepg-ex32_2.htm EX-32.2 7679
  Complete submission text file 0000950170-24-059519.txt   5896090

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT pepg-20240331.xsd EX-101.SCH 925798
57 EXTRACTED XBRL INSTANCE DOCUMENT pepg-20240331_htm.xml XML 670190
Mailing Address 1 MARINA PARK DRIVE, SUITE 900 BOSTON MA 02210
Business Address 1 MARINA PARK DRIVE, SUITE 900 BOSTON MA 02210 703-456-8000
PepGen Inc. (Filer) CIK: 0001835597 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41374 | Film No.: 24944235
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)